Showing results (11-20 of 60) with videos related to
Sort By:
Pageof 6
Bioconjugate Chemistry|May 22, 2003
Folate-targeted PEG as a potential carrier for carboplatin analogs. Synthesis and in vitro studiesOlga Aronov, Aviva T Horowitz, Alberto Gabizon, et al.Anti-Cancer Drugs|April 4, 2009
Long-term response to pegylated liposomal doxorubicin in patients with metastatic soft tissue sarcomasTal Grenader, Anthony Goldberg, Irit Hadas-Halperin, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|February 20, 2013
Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicityHilary Shmeeda, Yasmine Amitay, Dina Tzemach, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|January 26, 2016
Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicityYogita Patil, Yasmine Amitay, Patricia Ohana, et al.Oncology Reports|November 20, 2013
Diethylstilbestrol for the treatment of patients with castration-resistant prostate cancer: retrospective analysis of a single institution experienceTal Grenader, Yevgeni Plotkin, Maya Gips, et al.World Journal of Clinical Oncology|December 1, 2012
Pegylated liposomal doxorubicin/carboplatin combination in ovarian cancer, progressing on single-agent pegylated liposomal doxorubicinTal Grenader, Ora Rosengarten, Rut Isacson, et al.Anti-Cancer Drugs|March 14, 2003
Doxil-induced regression of pleuro-pulmonary metastases in a patient with malignant meningiomaMila Travitzky, Eugene Libson, Igor Nemirovsky, et al.Advanced Drug Delivery Reviews|September 18, 2012
Liposome imaging agents in personalized medicineAnncatrine L Petersen, Anders E Hansen, Alberto Gabizon, et al.Anti-Cancer Drugs|April 15, 2016
MEK inhibitor treatment is effective in a patient with metastatic carcinoma of the ampulla of Vater with BRAF and NRAS mutations shown by next-generation sequencingEsther Tahover, Rachel Bar Shalom, Naama Bogot, et al.Journal of Drug Targeting|April 10, 2003
Dose dependency of pharmacokinetics and therapeutic efficacy of pegylated liposomal doxorubicin (DOXIL) in murine modelsAlberto Gabizon, Dinah Tzemach, Lidia Mak, et al.Pageof 6